Incorporated - Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc.

Incorporated - Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc.
Ad-Hoc-News - 1 hour ago
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it has received $2 million in milestone payments from NV Organon, a subsidiary of Merck & Co., Inc., stemming from its ...